Pharmaron
Premier life sciences R&D services from discovery to commercialization
Beijing, China · Founded 2004 · $280.0M raised
- Headquarters
- Beijing
- Employees
- 10001+
- Founded
- 2004
- Business Model
- B2B
- Website
- pharmaron.com
- Total Funding
- $280.0M
- Last Round
- $280.0M Growth Equity
- Rounds
- 1
About
Pharmaron (Stock Code: 300759.SZ / 3759.HK) is a premier global life sciences service provider offering a fully integrated platform of research, development, and manufacturing services. Founded in 2004 by Dr. Boliang Lou in Beijing, China, Pharmaron supports the entire drug discovery and development lifecycle across multiple therapeutic modalities including small molecules, biologics, and cell and gene therapy (CGT) products. Services span laboratory chemistry, medicinal chemistry, in vitro and in vivo biology, DMPK, safety assessment, bioanalysis, chemistry manufacturing and controls (CMC), clinical development, and biologics CDMO. With over 25,000 employees and operations in China, the United States, and the United Kingdom, Pharmaron serves partners across North America, Europe, Japan, and China.
Summary
Pharmaron is a Biotech company based in Beijing, China, founded in 2004. It has raised $280.0M in total across 1 round. Investors include Legend Capital.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Unknown
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform

Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.